Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Hendifar, MD
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Los Angeles, California, United States
Recruiting - Boca Raton Regional Hospital, Lynn Cancer Institute
Boca Raton, Florida, United States
Recruiting - Williamette Valley Cancer Institute and Research Center
Eugene, Oregon, United States
Recruiting - Ahn Cancer Institute - Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Recruiting - Prisma Health - Upstate
Greenville, South Carolina, United States
Recruiting - Texas Oncology - Northeast Texas
Tyler, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2023
- Primary completion
- 28 Feb 2025
- Completion
- 31 May 2025
- Last update posted
- 14 Jun 2024
- Registered enrollment
- 30
- Registry id
- NCT05766748
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.